$HELE

Helen of Troy Ltd earnings beat by $0.28, revenue fell short of estimates

Helen of Troy Ltd (HELE) reported Q2 EPS of $0.79, beating estimates by $0.28, but revenue of $440.9M fell short of expectations. The company forecasted FY 2027 EPS of $3.60-$4.15 and revenue of $1.77B-$1.82B, both slightly below analyst consensus. The stock is down 3% over the last 3 months but up 23.37% year-over-year.

Original reporting
Published Oct 8, 2026, 10:50 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 8, 2026, 11:05 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$HELE
Bullish
high confidence
Mentioned
$HELE
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$HELEBullishHigh
01

Why it matters

The earnings beat provides a fresh catalyst for short‑term price movement, while guidance aligns with expectations, limiting long‑term upside.

02

Market read

New earnings data creates a trading opportunity for HELE; sector peers may be affected.

03

What to watch

Guidance range overlaps consensus; investors may wait for next quarter to confirm trend.

Relevance 8/10Novelty 8/10Timing: after-hours earnings release

Background

Helen of Troy (HELE) is a consumer products company listed on NASDAQ. The article provides its Q2 earnings and FY2027 guidance.

Company-level read

Ticker impact

$HELEBullishHigh confidence
Context

Helen of Troy reported Q2 EPS of $0.79, $0.28 above estimates and gave FY2027 guidance slightly above consensus.

Expected impact

likely modest upside as the earnings beat outweighs the slight revenue miss

Evidence & confidence

The surprise EPS beat is material and new; investors typically reward such earnings surprises, while the revenue shortfall is minor.

Market effects

Consumer products sector may see modest lift as a peer beats earnings.

U.S. market sentiment could improve slightly in the post‑earnings session.

Limited; impact confined to U.S. equities and sector peers.

Counterpoint

Revenue miss could signal demand weakness, suggesting caution.

Key entities

  • Helen of Troy Ltd

    NASDAQ‑listed consumer products manufacturer.

Related articles

$HELEMed

Helen of Troy Reports Second Quarter Fiscal 2027 Results

HELEN OF TROY LTD (HELE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Helen of Troy Reports Second Quarter Fiscal 2027 Results Consolidated Net Sales Growth of 2.1% GAAP Net Income of $4.6 Million; Diluted EPS of $0.19 Adjusted Income (1) of $19.0 Million; Adjusted Diluted EPS (1) of $0.79 Cash Flow From Operations of $57.1 Million; Ad

$MSMed

Dow gains over 150 points; Morgan Stanley profit tops views

U.S. stocks initially rose, with the Dow up 150 points, driven by strong earnings, including Morgan Stanley's Q2 EPS of $3.46 vs. estimates of $2.91. Later, markets reversed, with the Dow down 0.95%. European and Asian markets showed mixed performance. Commodities saw oil rise 5.6%, while gold and silver fell. Economic data included a rise in the Empire State manufacturing index and a decline in mortgage applications.

$HELEMedAI 8/10

Helen of Troy Q1 Earnings Call Highlights

Helen of Troy (NASDAQ:HELE) reported Q1 call highlights: Beauty and Wellness sales rose 7%, with wellness growth led by Braun, Vicks, Honeywell and PUR, while some core beauty brands faced POS pressure. International sales rose 1.1% on Osprey distribution. Margins were pressured by tariffs; gross margin fell to 46%. Full-year net sales guidance raised to $1.759B-$1.831B; adjusted EPS kept at $3.25-$3.75.

$HELEMedAI 8/10

Helen of Troy (HELE) Q1 2027 Earnings Call Transcript

Helen of Troy (HELE) reported Q1 FY2027 net sales of $402.1 million, up 8.2%, with adjusted diluted EPS of $0.17. Gross margin fell to 46.0% due to tariffs and mix. The company raised full-year net sales guidance to $1.759B-$1.831B and maintained free cash flow guidance of $85M-$100M, citing Prime Day phasing and tariff refund expectations.

$HELEMedAI 8/10

Helen of Troy reports surprise profit, raises revenue outlook

Helen of Troy (HELE) reported a surprise Q1 adjusted EPS of $0.17 versus a consensus loss of $0.01, with net sales up 8.2% to $402.1M, above forecasts. It raised fiscal 2027 revenue guidance to $1.76B-$1.83B, kept adjusted EPS at $3.25-$3.75. The company cited progress on Project Pegasus and tariff-related margin pressure.